19 September 2013. ASX welcomes Regeneus Limited. The Australian Securities Exchange (ASX) is pleased to announce that Regeneus Limited listed at 10:30am on Thursday, 19 September 2013.
Regeneus Limited is a regenerative medicine company. Its ASX ticker code is RGS.
The company raised $10.5 million by the issue of 42,000,000 fully paid ordinary shares at an issue price of $0.25 per share.
This is the 17th listing nationwide this financial year, bringing the total number of ASX-listed entities to 2,165. For further information: http://regeneus.com.au
Page 1994 of 2102
- Hunt for Queen's Wharf developer commences
- Queensland unit and townhouse sales climb
- Magazine seeks writers for online column in U.S.A, U.K., Asia & Australia. Writers wanted
- Perth median house price at new record
- Don’t let a bad credit score ruin your chances of a home loan
- The Importance of Communication for Business Success
- UK Innovator Visa: Getting Endorsement
- The Workers Launch Balmain's Biggest Laugh Free Live Comedy
- Surplus signals time for NSW Government to cut stamp duty
- Businesses
- Katter calls for better delivery of drought assistance
- Respected local restaurateurs are the icing on the Tweed River Art Gallery
- The Global Forest Industry This Quarter
- Lonely Planet names Kimberley as world’s second top tourism region for 2014
- Jazz Degustation + The Cellar Jazz Jam
- Record harvest ensures city fruit and veg supplies
- Progress for Canning Basin exploration
- ACCC action after chicken companies made false claims
- Vegan Australia says no to Bacon Week
- Commercial gas expansion boosts WA economy